Rabeprazole

Specifications

117976-89-3CAS Number

601-501-2EC Number

2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]-1H-benzimidazoleIUPAC Name

C18H21N3O3SChemical Formula

359.4 g/molMolecular Weight

rabeprazole; 117976-89-3; pariprazole; Eraloc; rabeprazol; LY307640; 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; LY-307640; CHEBI:8768; E-3810 (PPI); 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; LY 307640; 32828355LL; DTXSID3044122; 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-; 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-; 2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole; E3810; 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole; 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole; rabeprazolum; 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methane)sulfinyl)-1H-1,3-benzodiazole; 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methanesulfinyl)-1H-1,3-benzodiazole; 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole; 2-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl}-1H-benzimidazole; RefChem:57364; DTXCID1024122; A02BC04; Aciphex; Habeprazole; Pariets; 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; MFCD00868879; Rabeprazole (INN); RABEPRAZOLE [INN]; Rabeprazole [INN:BAN]; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; Rabeloc; Eraloc (TN); HSDB 7321; UNII-32828355LL; Rabeprazole (Standard); RABEPRAZOLE [MI]; RABEPRAZOLE [HSDB]; RABEPRAZOLE [VANDF]; CHEMBL1219; SCHEMBL23336; RABEPRAZOLE [WHO-DD]; MLS001401446; BIDD:GT0019; GTPL7290; orb1705951; SCHEMBL29360086; SCHEMBL29374701; HY-B0656R; (R)-2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; YREYEVIYCVEVJK-UHFFFAOYSA-N; BDBM651963; GLXC-07824; HMS2052P03; HMS3394P03; HMS5083P12; HY-B0656; BDBM50070209; EBC-26787; s4845; STL186112; US11903935, Compound IA-6; 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole; AKOS015895259; CCG-101158; DB01129; IM57864; NC00408; PB21725; NCGC00159518-10; NCGC00159518-12; NCGC00388029-07; NCGC00388029-09; AS-34993; SMR000469174; SBI-0206867.P001; DB-020298; DS-002860; NS00006247; Q3515; C07864; D08463; SBI-0206867.0001; T19826; AB00698237-06; EN300-7404394; SR-01000763041; SR-01000763041-3; BRD-A39390670-236-04-0; BRD-A39390670-236-09-9; BRD-A39390670-236-10-7; BRD-A39390670-236-11-5; BRD-A39390670-236-12-3; 1H-benzimidazole,2-[(r)-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-; 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl] sulfinyl]-1H-benzimidazole; 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole; 2-{[(3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl)methyl]sulphinyl}-1H-benzimidazole; 2-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methanesulfinyl}-1H-1,3-benzimidazole; 2-{4-(3-Methoxypropoxy)-3-methylpyridine-2-yl}methylsulfinyl-1H-benzimidazoleSynonyms